Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Fresenius SE & Co. KGaA (FREN) AI Stock Analysis

0 Followers
MX:FREN

Fresenius SE & Co. KGaA

(BMV:FREN)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Profit RecoveryThe sharp recovery in net income, alongside higher revenue and a stronger net margin, indicates that operating performance has materially improved. If maintained, this earnings base should support reinvestment, strengthen resilience, and provide a more durable platform for performance over the next several quarters.
Negative Factors
Debt BurdenAlthough leverage has improved, the absolute debt balance remains substantial relative to Fresenius’s healthcare services model. This can constrain capital allocation and leave less flexibility if profitability, utilization, or reimbursement trends weaken, making sustained deleveraging important to long-term stability.

Fresenius SE & Co. KGaA (FREN) vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%MX:FREN-0.01%SPY+8.82%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
MXN 608.38B
Dividend Yield
2.73%
Average Volume (3M)
―
Price to Earnings (P/E)
18.3
Beta (1Y)
0.03
Revenue Growth
0.58%
EPS Growth
27.62%
Country
Mexico
Employees
178,394
Sector
General
Sector Strength
55
Industry
Medical - Care Facilities

Fresenius SE & Co. KGaA Business Overview & Revenue Model

Company Description

Fresenius SE & Co. KGaA operates as a diverse healthcare enterprise, supplying a comprehensive array of products and services primarily focused on dialysis, hospital management, and outpatient medical care. Its activities are structured across four m...

Fresenius SE & Co. KGaA Peers Comparison

Overall Rating

Financial Indicators

MX:FREN against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

0%0%0%0%0%MX:FRENDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MX:FREN and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:FRENFresenius SE & Co. KGaA791.93-0.07>-0.01%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.